BCL2L1 and hepatocellular carcinoma: As depicted in Figure 4, western blot analysis confirmed overexpression of Bcl-xL in a subset of human liver cancer specimens (hepatocellular carcinoma, adenocarcinoma but not cholangiocellular carcinoma) compared to normal liver (and placenta).